Evidence for PTZ-like cues as a function of time following treatment with chlordiazepoxide: Implications for understanding tolerance and withdrawal

Behavioural Pharmacology

Volumn 16, Issue 3, 2005, Pages 147-153

  Barrett, Robert J ^a,c   Smith, R L ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chlordiazepoxide; Drug discrimination; Pentylenetetrazol; Rat

Indexed keywords

CHLORDIAZEPOXIDE; PENTETRAZOLE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; CONTROLLED STUDY; DISCRIMINATION LEARNING; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG TOLERANCE; MALE; NONHUMAN; RAT; REINFORCEMENT; WITHDRAWAL SYNDROME;

ANIMALS; ANTI-ANXIETY AGENTS; CHLORDIAZEPOXIDE; DISCRIMINATION LEARNING; GABA AGONISTS; MALE; MOTIVATION; PENTYLENETETRAZOLE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 18844444794     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200505000-00003     Document Type: Article

References (39)

1. Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC (2004). Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev 111:33-51.
2. Barrett RJ (1985). Behavioral approaches to individual differences in substance abuse. In: Galizio M, Maisto S (editors): Determinants of Substance Abuse. New York: Plenum Press; pp. 125-175.
3. Barrett RJ, Smith RL (1988). Time dependent pentylenetetrazol-like cues subsequent to diazepam administration. Psychopharmacology (Berl) 96:169-173.
4. Barrett RJ, White DK, Caul WF (1992). Tolerance, withdrawal and supersensitivity to dopamine mediated cues in a drug-drug discrimination. Psychopharmacology (Berl) 109:63-67.
5. Barrett RJ, Caul WF, Huffman EM, Smith RL (1994). Drug discrimination is a continuous rather than quantal process following training on a VI-TO schedule of reinforcement. Psychopharmacology (Berl) 113:289-296.
6. Barrett RJ, Caul WF, Stadler JR, Smith RL (2001). Long-lasting rebound cue effects following single doses of nicotine and amphetamine: implications for understanding tolerance. Psychopharmacology (Berl) 57:349-357.
7. Barrett RJ, Caul WF, Smith RL (2004). Evidence for bidirectional cues as a function of time following treatment with amphetamine: implications for understanding tolerance and withdrawal. Pharmacol Biochem Behav 79:761-771.
8. Barrett RJ, Caul WF, Smith RL (2005). Evidence for bidirectional cues as a function of time following treatment with amphetamine: Implications for understanding tolerance and withdrawal. Pharmacol Biochem Behav (in press).
9. Cohen S (1984). Cocaine: Acute medical and psychiatric complications. Psychiatr Ann 14:747-749.
10. Colpaert FC (1996). System theory of pain and of opiate analgesia: no tolerance to opiates. Pharmacol Rev 48:355-402.
11. DSM III American Psychiatric Association (1980.) Diagnostic and Statistical Manual. Washington, DC: American Psychiatric Association.
12. Fraser AD (1998). Use and abuse of the benzodiazepines. Ther Drug Monit 20:481-489.
13. Geller I, Seifter J (1960). The effects of meprobamate, barbiturates, D-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia 1:482-492.
14. Gold MS, Verebey K (1984). The psychopharmacology of cocaine. Psychiatr Ann 14:714-723.
15. Gossop M, Darke S, Griffiths PHJ, Powis B, Hall W, Strang J (1995). The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 90:607-614.
16. Jellinek EM (1952). Phases of alcohol addiction. Q J Stud Alcohol 13:673-684.
17. Jellinek EM (1960). The Disease Concept of Alcoholism. New Brunswick, NJ: Hillhouse Press.
18. Khantzian EJ, Khantzian NJ (1984). Cocaine addiction: Is there a psychological predisposition? Psychiatr Ann 14:753-759.
19. Kleber HD, Gawin FH (1984). The spectrum of cocaine abuse and its treatment. J Clin Psychiatry 45:18-23.
20. Koob GF, Stinus L, Le Moal M, Bloom FE (1989). Opponent-process theory of motivation: neurobiological evidence from studies of opiate dependence. Neurosci Biobehav Rev 13:135-140.
21. Koob GF, Caine SB, Parsons L, Markou A, Weiss F (1997). Opponent process model of addiction. Pharmacol Biochem Behav 57:513-521.
22. Kozlowski LT, Wilkinson A, Skinner W, Kent C, Franklin T, Pope M (1989). Comparing tobacco cigarette dependence with other drug dependencies. JAMA 261:898-901.
23. Lago JA, Kosten TR (1994). Stimulant withdrawal. Addiction 89:1477-1482.
24. Larcher A, Laulin JP, Celerier E, Le Moal M, Simonnet G (1998). Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems. Neuroscience 84:583-589.
25. Laulin JP, Celerier E, Larcher A, Le Moal M, Simonnet G (1999). Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity. Neuroscience 89:631-636.
26. Ludwig AM, Stark LH (1974). Alcohol craving: Subjective and situational aspects. Q J Stud Alcohol 35:899-905.
27. Michaelis RC, Holohean AM, Criado JR, Harland RD, Hunter GA, Holloway FA (1988). The chlordiazepoxide/pentylenetetrazol discrimination: characterization of drug interactions and homeostatic responses to drug challenges. Psychopharmacology (Berl) 96:15-20.
28. Mule SJ (1984). The pharmacodynamics of cocaine abuse. Psychiatr Ann 14:724-727.
29. Rodin EA (1958). Metrazol tolerance in a 'normal' and volunteer population. Electroencephalogr Clin Neurophysiol 10:433-446.
30. Rodin EA, Calhoun HD (1970). Metrazol in a 'normal' volunteer population. J Nerv Ment Dis 150:438-450.
31. Rynn MA, Brawman-Mintzer O (2004). Generalized anxiety disorder: acute and chronic treatment. CNS Spectr 9:716-723.
32. Smith RL, Barrett RJ (1997). Tolerance to the anticonflict effects of diazepam: importance of methodological considerations. Pharmacol Biochem Behav 58:61-66.
33. Solomon RL (1980). The opponent-process theory of acquired motivation: the costs of pleasure and the benefits of pain. Am Psychol 35:691-712.
34. Spealman RD (1986). Disruption of schedule-controlled behavior by Ro 15-1788 one day after acute treatment with benzodiazepines. Psychopharmacology (Berl) 88:398-400.
35. Stockwell T (1994). Alcohol withdrawal: An adaptation to heavy drinking of no practical significance? Addiction 89:1447-1453.
36. Stolerman IP, Jarvis MJ (1995). The scientific case that nicotine is addictive. Psychopharmacology (Berl) 117:2-20.
37. Stewart J, DeWit H, Eikelboom R (1984). Role of conditioned and unconditioned drug effects in the self-administration of opiates and stimulants. Psychol Rev 91:251-268.
38. Wikler A (1980). Opioid Dependence. New York: Plenum.
39. Wise RA, Bozarth MA (1987). A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492.